GLUE
Price
$20.69
Change
+$2.02 (+10.82%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.75B
44 days until earnings call
Intraday BUY SELL Signals
IMNM
Price
$19.34
Change
+$0.16 (+0.83%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.19B
57 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs IMNM

GLUE vs IMNM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GLUE vs. IMNM commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Buy and IMNM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (GLUE: $18.66 vs. IMNM: $19.18)
Brand notoriety: GLUE and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 192% vs. IMNM: 107%
Market capitalization -- GLUE: $1.58B vs. IMNM: $2.17B
GLUE [@Biotechnology] is valued at $1.58B. IMNM’s [@Biotechnology] market capitalization is $2.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, GLUE is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 5 bullish TA indicator(s).

  • GLUE’s TA Score: 5 bullish, 5 bearish.
  • IMNM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than GLUE.

Price Growth

GLUE (@Biotechnology) experienced а +2.98% price change this week, while IMNM (@Biotechnology) price change was +6.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

GLUE is expected to report earnings on Aug 06, 2026.

IMNM is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.19B) has a higher market cap than GLUE($1.75B). GLUE YTD gains are higher at: 19.005 vs. IMNM (-10.708). GLUE has higher annual earnings (EBITDA): -139.94M vs. IMNM (-235.83M). GLUE has more cash in the bank: 666M vs. IMNM (583M). IMNM has less debt than GLUE: IMNM (3.69M) vs GLUE (39.1M). GLUE has higher revenues than IMNM: GLUE (43M) vs IMNM (4.02M).
GLUEIMNMGLUE / IMNM
Capitalization1.75B2.19B80%
EBITDA-139.94M-235.83M59%
Gain YTD19.005-10.708-177%
P/E Ratio49.25N/A-
Revenue43M4.02M1,071%
Total Cash666M583M114%
Total Debt39.1M3.69M1,058%
TECHNICAL ANALYSIS
Technical Analysis
GLUEIMNM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
IMNM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBHL25.38N/A
-0.02%
iShares iBonds 2032 Term HY and Inc ETF
ALTY12.30-0.01
-0.12%
Global X Alternative Income ETF
ADME55.65-0.21
-0.38%
Aptus Drawdown Managed Equity ETF
LFGY22.98-0.15
-0.65%
YieldMax Crypto Industry & Tech Portfolio Option Income ETF
ARKW143.27-3.36
-2.29%
ARK Next Generation Internet ETF

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with CRNX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
+1.91%
CRNX - GLUE
42%
Loosely correlated
-1.37%
IMNM - GLUE
38%
Loosely correlated
+2.35%
AXON - GLUE
38%
Loosely correlated
-3.16%
RVMD - GLUE
37%
Loosely correlated
+1.73%
KURA - GLUE
37%
Loosely correlated
+4.33%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KURA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+2.35%
KURA - IMNM
50%
Loosely correlated
+4.33%
KYTX - IMNM
46%
Loosely correlated
+2.91%
NRIX - IMNM
45%
Loosely correlated
+6.27%
VYGR - IMNM
44%
Loosely correlated
N/A
RLAY - IMNM
44%
Loosely correlated
+8.82%
More